Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials

PURPOSE: We compared efficacy of trastuzumab versus no trastuzumab in patients with small (≤ 2 cm) human epidermal growth factor receptor 2 (HER2) –positive breast cancer treated in randomized trials. METHODS: A meta-analysis was conducted using data from five of the six adjuvant trastuzumab trials....

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Oncol
Huvudupphovsmän: O'Sullivan, Ciara C., Bradbury, Ian, Campbell, Christine, Spielmann, Marc, Perez, Edith A., Joensuu, Heikki, Costantino, Joseph P., Delaloge, Suzette, Rastogi, Priya, Zardavas, Dimitrios, Ballman, Karla V., Holmes, Eileen, de Azambuja, Evandro, Piccart-Gebhart, Martine, Zujewski, Jo Anne, Gelber, Richard D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2015
Ämnen:
ORIGINAL REPORTS
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534523/
https://ncbi.nlm.nih.gov/pubmed/26101239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.60.8620
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk